{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:52:31Z","timestamp":1787961151466,"version":"build-2784847793"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Equine Practice"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cveq.2024.07.006","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T14:54:08Z","timestamp":1724511248000},"page":"409-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["What Is the Evidence Behind Sarcoid Treatments?"],"prefix":"10.1016","volume":"40","author":[{"given":"Anna R.","family":"Hollis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cveq.2024.07.006_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1463-5224.2000.00119.x","article-title":"The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974 to 1999","volume":"3","author":"Knottenbelt","year":"2000","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cveq.2024.07.006_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/vr.149.22.665","article-title":"Evaluation of excision, cryosurgery and local BCG vaccination for the treatment of equine sarcoids","volume":"149","author":"Martens","year":"2001","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2024.07.006_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2460\/javma.249.3.311","article-title":"Treatment of sarcoids in equids: 230 cases (2008-2013)","volume":"249","author":"Haspeslagh","year":"2016","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2024.07.006_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/00480169.1994.35816","article-title":"Management of equine sarcoids: 1975-1993","volume":"42","author":"McConaghy","year":"1994","journal-title":"N\u00a0Z Vet J"},{"key":"10.1016\/j.cveq.2024.07.006_bib5","first-page":"S416","article-title":"Equine sarcoids, causes, diagnosis, and treatment","volume":"5","author":"Genetzky","year":"1983","journal-title":"Compend Continuing Educ Pract Vet"},{"key":"10.1016\/j.cveq.2024.07.006_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/jvet.2001.25874","article-title":"Polymerase chain reaction analysis of the surgical margins of equine sarcoids for bovine papilloma virus DNA","volume":"30","author":"Martens","year":"2001","journal-title":"Vet Surg"},{"key":"10.1016\/j.cveq.2024.07.006_bib7","first-page":"773","article-title":"Carbon dioxide laser as a surgical instrument for sarcoid therapy--a retrospective study on 60 cases","volume":"38","author":"Carstanjen","year":"1997","journal-title":"Can Vet J"},{"key":"10.1016\/j.cveq.2024.07.006_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/evj.12456","article-title":"Laser surgery as a treatment for histologically confirmed sarcoids in the horse","volume":"48","author":"Compston","year":"2016","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.07.006_bib9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2460\/javma.2002.220.1192","article-title":"Use of a carbon dioxide laser for surgical management of cutaneous masses in horses: 32 cases (1993-2000)","volume":"220","author":"McCauley","year":"2002","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2024.07.006_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.2042-3306.1977.tb04003.x","article-title":"The treatment of equine sarcoids by cryosurgery","volume":"9","author":"Lane","year":"1977","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.07.006_bib11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0195-5616(80)50085-9","article-title":"Prospective analysis of cryosurgery as the sole treatment for equine sarcoids","volume":"10","author":"Fretz","year":"1980","journal-title":"Vet Clin N Am Equine Pract"},{"key":"10.1016\/j.cveq.2024.07.006_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijgo.2010.04.032","article-title":"Performance of cryotherapy devices using nitrous oxide and carbon dioxide","volume":"111","author":"Winkler","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.cveq.2024.07.006_bib13","first-page":"386","article-title":"Review of the treatment of equine cutaneous neoplasia","volume":"55","author":"Hewes","year":"2009","journal-title":"AAEP proceedings"},{"key":"10.1016\/j.cveq.2024.07.006_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/eve.12817","article-title":"Radiotherapy for the treatment of periocular tumours in the horse","volume":"31","author":"Hollis","year":"2019","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2024.07.006_bib15","article-title":"Treatment of periocular tumours - what is the evidence?","volume":"66","author":"Malalana","year":"2015","journal-title":"BEVA congress"},{"key":"10.1016\/j.cveq.2024.07.006_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/eve.12950","article-title":"A\u00a0pilot study on the use of ultra-deformable liposomes containing bleomycin in the treatment of equine sarcoid","volume":"32","author":"Knottenbelt","year":"2018","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2024.07.006_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.2042-3292.1994.tb01089.x","article-title":"Topical treatment of the equine sarcoid","volume":"6","author":"Knottenbelt","year":"1994","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2024.07.006_bib18","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1111\/eve.13761","article-title":"Evisceration in a Thoroughbred gelding following application of a topical chemotherapy agent for the treatment of sarcoids","volume":"35","author":"Baldwin","year":"2023","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2024.07.006_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-3164.2006.00526.x","article-title":"Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study","volume":"17","author":"Nogueira","year":"2006","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.cveq.2024.07.006_bib20","doi-asserted-by":"crossref","first-page":"471-e126","DOI":"10.1111\/vde.12900","article-title":"Topical treatment of equine sarcoids with imiquimod 5% cream or Sanguinaria canadensis and zinc chloride - an open prospective study","volume":"31","author":"Pettersson","year":"2020","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.cveq.2024.07.006_bib21","first-page":"709","article-title":"Use of combination of tazarotene cream and imiquimod 5% cream in the treatment of equine sarcoids: a 20 case retrospective study","volume":"28","author":"Tamzali","year":"2014","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.07.006_bib22","first-page":"704","article-title":"Efficacy of bloodroot ointment for the treatment of equine sarcoids","volume":"28","author":"Wilford","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.07.006_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/vr.c5430","article-title":"Successful treatment of equine sarcoids by topical aciclovir application","volume":"168","author":"Stadler","year":"2011","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2024.07.006_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12917-017-1215-0","article-title":"Topical use of 5% acyclovir cream for the treatment of occult and verrucous equine sarcoids: a double-blinded placebo-controlled study","volume":"13","author":"Haspeslagh","year":"2017","journal-title":"BMC Vet Res"},{"issue":"Suppl B","key":"10.1016\/j.cveq.2024.07.006_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/12.suppl_B.9","article-title":"The biochemistry and mechanism of action of acyclovir","volume":"12","author":"Elion","year":"1983","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cveq.2024.07.006_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12917-020-2262-5","article-title":"Betulinic acid shows anticancer activity against equine melanoma cells and permeates isolated equine skin in\u00a0vitro","volume":"16","author":"Weber","year":"2020","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.cveq.2024.07.006_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jvp.12903","article-title":"Concentration profiles and safety of topically applied betulinic acid and NVX-207 in eight healthy horses-A randomized, blinded, placebo-controlled, crossover pilot study","volume":"44","author":"Weber","year":"2021","journal-title":"J\u00a0Vet Pharmacol Therapeut"},{"key":"10.1016\/j.cveq.2024.07.006_bib28","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.2460\/javma.230.10.1506","article-title":"Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995-2004)","volume":"230","author":"Theon","year":"2007","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2024.07.006_bib29","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2460\/javma.229.10.1617","article-title":"Use of cisplatin-containing biodegradable beads for treatment of cutaneous neoplasia in equidae: 59 cases (2000-2004)","volume":"229","author":"Hewes","year":"2006","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2024.07.006_bib30","first-page":"704","article-title":"A\u00a0practical protocol for the clinical use of mitomycin C in the treatment of sarcoids in horses","volume":"28","author":"McKane","year":"2014","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.07.006_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1751-0813.2006.tb12239.x","article-title":"The efficacy of intratumoural 5-fluorouracil for the treatment of equine sarcoids","volume":"84","author":"Stewart","year":"2006","journal-title":"Aust Vet J"},{"key":"10.1016\/j.cveq.2024.07.006_bib32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fvets.2020.00639","article-title":"Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses","volume":"7","author":"De Ridder","year":"2020","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.cveq.2024.07.006_bib33","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/jvim.16425","article-title":"ALVAC-fIL2, a feline interleukin-2 immunomodulator, as a treatment for sarcoids in horses: A pilot study","volume":"36","author":"Saba","year":"2022","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.07.006_bib34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/vr.103867","article-title":"Electrochemotherapy as a single or adjuvant treatment to surgery of cutaneous sarcoid tumours in horses: a 31-case retrospective study","volume":"179","author":"Tozon","year":"2016","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2024.07.006_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1567-5394(01)00156-6","article-title":"Electrochemotherapy of horses. A preliminary clinical report","volume":"55","author":"Rols","year":"2002","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.cveq.2024.07.006_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.2042-3306.2011.00425.x","article-title":"Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases","volume":"44","author":"Tamzali","year":"2012","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.07.006_bib37","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/vco.12299","article-title":"Glycolysis inhibition improves photodynamic therapy response rates for equine sarcoids","volume":"15","author":"Golding","year":"2017","journal-title":"Vet Comp Oncol"},{"key":"10.1016\/j.cveq.2024.07.006_bib38","first-page":"143","article-title":"Bacillus Calmette-Guerin as an anti-tumor agent. The interaction with cells of the mammalian immune system","volume":"651","author":"Davies","year":"1982","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cveq.2024.07.006_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00205581","article-title":"Clinico-pathological aspects of immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma","volume":"20","author":"Misdorp","year":"1985","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.cveq.2024.07.006_bib40","doi-asserted-by":"crossref","first-page":"103102","DOI":"10.1016\/j.jevs.2020.103102","article-title":"Evaluation of locally injected mycobacterium cell wall fraction in horses with sarcoids","volume":"90","author":"Caston","year":"2020","journal-title":"J\u00a0Equine Vet Sci"},{"key":"10.1016\/j.cveq.2024.07.006_bib41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.2042-3306.1985.tb02552.x","article-title":"BCG treatment of periocular sarcoid","volume":"17","author":"Lavach","year":"1985","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.07.006_bib42","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.2042-3306.1988.tb01571.x","article-title":"BCG emulsion immunotherapy of equine sarcoid","volume":"20","author":"Vanselow","year":"1988","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2024.07.006_bib43","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/vr.120.23.548","article-title":"Clinical observations on the use of BCG cell wall fraction for treatment of periocular and other equine sarcoids","volume":"120","author":"Owen","year":"1987","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2024.07.006_bib44","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0749-0739(17)30189-X","article-title":"Equine sarcoids","volume":"14","author":"Goodrich","year":"1998","journal-title":"Vet Clin N Am Equine Pract"},{"key":"10.1016\/j.cveq.2024.07.006_bib45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/eve.12782","article-title":"Initial experience with High Dose Rate Brachytherapy of periorbital sarcoids in the horse","volume":"30","author":"Hollis","year":"2018","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2024.07.006_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/eve.13038","article-title":"Strontium-90 plesiotherapy in the horse","volume":"32","author":"Hollis","year":"2017","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2024.07.006_bib47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.2042-3292.2004.tb00319.x","article-title":"Use of radiation therapy in the treatment of equine neoplasia","volume":"16","author":"Henson","year":"2004","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2024.07.006_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/eve.12420","article-title":"Electronic brachytherapy used for the successful treatment of three different types of equine tumours","volume":"29","author":"Bradley","year":"2017","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2024.07.006_bib49","first-page":"68","article-title":"How to treat equine sarcoids by autologous implantation","author":"Espy","year":"2008","journal-title":"Proceedings, 54th Annual American Association of Equine Practitioners Convention"},{"key":"10.1016\/j.cveq.2024.07.006_bib50","first-page":"3367","article-title":"Equine sarcoid tumour treated by autogenous tumour vaccine","volume":"19","author":"Kinnunen","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cveq.2024.07.006_bib51","first-page":"709","article-title":"Autologous vaccination for the treatment of equine sarcoids: 18 cases (2009-2014)","volume":"56","author":"Rothacker","year":"2015","journal-title":"Can Vet J"},{"key":"10.1016\/j.cveq.2024.07.006_bib52","series-title":"Principles of oncological therapy clinical equine oncology","first-page":"192","author":"Kottenbelt","year":"2015"},{"key":"10.1016\/j.cveq.2024.07.006_bib53","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1939-1676.2010.0597.x","article-title":"Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (Viscum album austriacus)","volume":"24","author":"Christen-Clottu","year":"2010","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.07.006_bib54","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/jvim.12144","article-title":"A\u00a0pilot phase II study of the efficacy and biosafety of doxorubicin chemotherapy in tumor-bearing equidae","volume":"27","author":"Theon","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2024.07.006_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.12968\/ukve.2018.2.5.145","article-title":"Managing periocular sarcoids","volume":"2","author":"Hollis","year":"2018","journal-title":"UK-Vet Equine"},{"issue":"1","key":"10.1016\/j.cveq.2024.07.006_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/evj.13935","article-title":"Treatment of equine sarcoids: a systematic review","volume":"56","author":"Offer","year":"2023","journal-title":"Equine Vet J"}],"container-title":["Veterinary Clinics of North America: Equine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073924000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073924000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T04:22:48Z","timestamp":1730348568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749073924000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0749073924000555"],"URL":"https:\/\/doi.org\/10.1016\/j.cveq.2024.07.006","relation":{},"ISSN":["0749-0739"],"issn-type":[{"value":"0749-0739","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What Is the Evidence Behind Sarcoid Treatments?","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Equine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cveq.2024.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}